Solriamfetol bulk supplier for pharma manufacturers

Solriamfetol 75 mg, 150 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 75 mg, 150 mg

Reference Brands: Sunosi (USA/EU)

Solriamfetol is a Antipsychotropic Drugs product available as Tablets in strengths 75 mg, 150 mg. It corresponds to the reference brand Sunosi (USA/EU). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Solriamfetol? List it or send an offer →

Product Description:

Solriamfetol is a wakefulness-promoting medication used for the treatment of excessive daytime sleepiness in adults with narcolepsy or obstructive sleep apnea. It acts as a dopamine and norepinephrine reuptake inhibitor, helping increase alertness and improve the ability to stay awake during the day. Unlike traditional stimulants, solriamfetol has a targeted mechanism that supports sustained wakefulness with a controlled effect on central nervous system pathways.

The medicine is taken orally and is intended to improve daytime functioning in patients whose sleepiness persists despite appropriate management of underlying conditions, such as continuous positive airway pressure (CPAP) therapy for obstructive sleep apnea. Clinical studies have shown that solriamfetol provides meaningful improvement in wakefulness and daily performance measures, and in some comparisons it has demonstrated stronger effects on excessive daytime sleepiness than several other wakefulness-promoting agents. It is marketed under the brand name Sunosi and is approved in multiple regions for adult use under medical supervision, with dosing individualized based on response and tolerability.

Controlled medicine — licensed supply only

This product is controlled in many countries under narcotic, psychotropic, precursor or other drug laws, which vary by country. We supply only licensed buyers holding any import certificate, permit or authorisation their national authority requires, and the Indian manufacturer or exporter must hold the required licences. In India, each export of a narcotic drug or psychotropic substance needs an export authorisation, and export of ephedrine, pseudoephedrine or their preparations a No Objection Certificate, from the Narcotics Commissioner (Central Bureau of Narcotics). We verify permits before quoting.

Solriamfetol — third party manufacturing & bulk supply

Solriamfetol 75 mg, 150 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Solriamfetol is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Solriamfetol listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Solriamfetol →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Solriamfetol is used to improve wakefulness in adults who have excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea (OSA). It helps increase alertness during the day but does not treat the underlying airway obstruction in OSA.

It is a synthetic central nervous system stimulant-type agent that works as a dopamine and norepinephrine reuptake inhibitor, formulated as solriamfetol hydrochloride in oral tablet form.

The trade name is Sunosi.

It is marketed by Axsome Therapeutics (rights acquired from Jazz Pharmaceuticals in several regions).

The generic name is solriamfetol hydrochloride.

The brand name is Sunosi.

It is manufactured in globally approved pharmaceutical manufacturing facilities operating under US and EU regulatory standards by licensed manufacturers for the marketing company.